| |
|
|
|
Galectin Therapeutic  
|
|
3.03 0.08 (0.03%) |
05-29 16:00 |
|
Open: |
2.91 |
Pre close: |
2.95 |
Target:
|
4.15
|
|
High: |
3.05 |
Low: |
2.88 |
Resistance:
|
3.55
4.15
|
|
Volume: |
183,515 |
Market Cap: |
173M |
Support:
|
2.44
1.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.06
 |
MACD |
MACD(12,26):
|
0.22  |
|
MA(20): |
2.81 |
Signal(12,26,9): |
0.22 |
|
MA(100): |
2.38 |
Stochastic Oscillator |
%K(14,3):
|
76.62 |
|
MA(250): |
3.10 |
%D(3): |
81.96 |
|
Average Volume(K) |
3-Month: |
29241
|
52-Week |
High:
|
4.50 |
|
10-Days: |
25992 |
Low: |
1.50 |
|
RSI |
RSI(14):
|
62.26 |
Change(%): |
-22.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.265 |
Return on Equity (ttm) |
-58.4 |
Shares Out. (M) |
57.03 |
|
EPS Est. Current Year |
-0.530 |
Return on Assets (ttm) |
-35.3 |
Shares Float (M) |
41.09 |
|
EPS Est. Next Year |
-0.520 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.34 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
17.47 |
|
Forward EPS |
-0.380 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5600 |
|
Book Value (p.s.) |
0.710 |
EBITDA (p.s.) |
0.000 |
P/E |
-11.43 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.27 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.94 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-7.12 |
P/CF |
-14.47 |
|
|
|
|
|
|
